{"nct_id":"NCT03548207","title":"A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants With Relapsed or Refractory Multiple Myeloma","status":"COMPLETED","status_verified_date":"2025-07","start_date":"2018-06-29","start_date_type":"ACTUAL","primary_completion_date":"2022-08-23","primary_completion_date_type":"ACTUAL","completion_date":"2022-08-23","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["JNJ"]}